doi: 10.1001/jama.1946.02870380008004.
Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders
- PMID: 20997191
- DOI: 10.1001/jama.1946.02870380008004
Item in Clipboard
Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders
J Am Med Assoc.
.
No abstract available
Similar articles
-
[Effect of methyl-bis (beta-chloroethyl)amine hydrochloride on Hodgkin's disease, lymphosarcoma, leukemia and neoplasms].Riv Patol Clin. 1951 Jan;6(1):1-58. Riv Patol Clin. 1951. PMID: 14834735 Undetermined Language. No abstract available.
-
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan.JAMA. 1984 May 4;251(17):2255-61. doi: 10.1001/jama.251.17.2255. JAMA. 1984. PMID: 6368885 No abstract available.
-
Nitrogen mustard therapy; studies on the effect of methyl-bis (beta-chloroethyl) amine hydrochloride on neoplastic diseases and allied disorders of the hemopoietic system.J Am Med Assoc. 1946 Oct 5;132:263-71. doi: 10.1001/jama.1946.02870400011003. J Am Med Assoc. 1946. PMID: 20997209 No abstract available.
-
Nitrogen mustard therapy; the use of methyl bis (B chloroethyl) amine hydrochloride in Hodgkin's disease, leukemia, lymphosarcoma and cancer of the lung.Am J Med Sci. 1949 Feb;217(2):162-8. Am J Med Sci. 1949. PMID: 18109277 No abstract available.
-
Mechlorethamine.2023 Apr 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Apr 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 37094062 Free Books & Documents. Review.
Cited by
-
Withaferin-A Inhibits Growth of Drug-Resistant Breast Carcinoma by Inducing Apoptosis and Autophagy, Endogenous Reactive Oxygen Species (ROS) Production, and Inhibition of Cell Migration and Nuclear Factor kappa B (Nf-κB)/Mammalian Target of Rapamycin (m-TOR) Signalling Pathway.Med Sci Monit. 2019 Sep 12;25:6855-6863. doi: 10.12659/MSM.916931. Med Sci Monit. 2019. Retraction in: Med Sci Monit. 2021 Mar 25;27:e932348. doi: 10.12659/MSM.932348. PMID: 31512681 Free PMC article. Retracted.
-
Clinical trial design: Past, present, and future in the context of big data and precision medicine.Cancer. 2020 Nov 15;126(22):4838-4846. doi: 10.1002/cncr.33205. Epub 2020 Sep 15. Cancer. 2020. PMID: 32931022 Free PMC article. Review.
-
Observations of unprecedented remissions following novel treatment for acute leukemia in children in 1948.J R Soc Med. 2012 Apr;105(4):177-81. doi: 10.1258/jrsm.2012.12k013. J R Soc Med. 2012. PMID: 22532657 Free PMC article. Review. No abstract available.
-
Chemotherapy: how to reduce its adverse effects while maintaining the potency?Med Oncol. 2023 Feb 3;40(3):88. doi: 10.1007/s12032-023-01954-6. Med Oncol. 2023. PMID: 36735206 Review.
-
The birth of chemotherapy at Yale. Bicentennial lecture series: Surgery Grand Round.Yale J Biol Med. 2011 Jun;84(2):169-72. Yale J Biol Med. 2011. PMID: 21698052 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous